Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Orgenesis
Orgenesis
Activities:
Research & Development
Pharmaceutical
Cell & Gene Therapy
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Regulatory
Orgenesis and Theracell collaboration designated priority investment in Greece
As a result of this designation, the venture will be inducted into the country’s fast-track licensing and approval process
Research & Development
Orgenesis announces collaboration with Tel Aviv Medical Center
The collaboration aims to advance point-of-care development and commercialisation of cell and gene and therapies
Finance
Orgenesis to collaborate with Savicell on ImmunoBiopsy platform
The collaboration aims to develop and validate diagnostic kits for enhanced quality control (QC) and monitoring purposes to be used by Orgenesis for CGT applications
Research & Development
Orgenesis to trial Tissue Genesis Icellator tech for cell recovery
The trial is supported by the National Stem Cell Foundation and an OREF clinical research grant in cellular therapy in honour of James Urbaniak, MD
Drug Delivery
Orgenesis signs joint venture with Cure Therapeutics
The agreement aims to to advance point-of-care development and commercialisation of cell and gene therapies
Pharmaceutical
Orgenesis launches cell-based vaccine platform targeting SARS-CoV-2
US biotech has created a cell-based vaccine platform targeting solid tumours for use against viral diseases
Finance
Orgenesis acquires cell therapy manufacturer MaSTherCell
Acquisition to accelerate type 1 diabetes therapeutic into clinical trials and diversify future business model and product offering
Subscribe now